Tech Company Financing Transactions

Matchpoint Therapeutics Funding Round

On 10/17/2022, Matchpoint Therapeutics raised $100 million in investment from Access Biotechnology, Atlas Venture and Sanofi-Genzyme BioVentures.

Transaction Overview

Announced On
10/17/2022
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds for further advancement of its proprietary platform and its discovery pipeline of novel covalent molecules, initially focused on immunology.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq.
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
Our core values serve as the foundation for everything we do. Matchpoint brings together passionate drug hunters, deep technical experts, and seasoned company builders unified by the goal of developing precision covalent medicines that transform the lives of those impacted by serious disease.
Profile
Matchpoint Therapeutics LinkedIn Company Profile
Social Media
Matchpoint Therapeutics Company Twitter Account
Company News
Matchpoint Therapeutics News
Facebook
Matchpoint Therapeutics on Facebook
YouTube
Matchpoint Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andre Turenne
  Andre Turenne LinkedIn Profile  Andre Turenne Twitter Account  Andre Turenne News  Andre Turenne on Facebook
Chief Scientific Officer
Jared Cumming
  Jared Cumming LinkedIn Profile  Jared Cumming Twitter Account  Jared Cumming News  Jared Cumming on Facebook
Chief Technical Officer
Mark Tebbe
  Mark Tebbe LinkedIn Profile  Mark Tebbe Twitter Account  Mark Tebbe News  Mark Tebbe on Facebook
Vice President
Wei Li
  Wei Li LinkedIn Profile  Wei Li Twitter Account  Wei Li News  Wei Li on Facebook
Vice President
Paul Renhowe
  Paul Renhowe LinkedIn Profile  Paul Renhowe Twitter Account  Paul Renhowe News  Paul Renhowe on Facebook
Vice President
Suresh Singh
  Suresh Singh LinkedIn Profile  Suresh Singh Twitter Account  Suresh Singh News  Suresh Singh on Facebook
VP - Operations
Christopher Hren
  Christopher Hren LinkedIn Profile  Christopher Hren Twitter Account  Christopher Hren News  Christopher Hren on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/17/2022: Quantum Systems venture capital transaction
Next: 10/18/2022: Nitricity venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary